Josef Pfeilschifter

Cerivastatin inhibits proliferation of interleukin-1 beta-induced rat mesangial cells by enhanced formation of nitric oxide.

J. Pfeilschifter, K. Schrör, B. Grabensee, 2004, European journal of pharmacology.

Protein Kinase C-dependent Phosphorylation of the mRNA-stabilizing Factor HuR : Implications for Posttranscriptional Regulation of Cyclooxygenase-2

Heinfried H Radeke, J. Pfeilschifter, A. Huwiler, 2007 .

Coexpression of tyrosine hydroxylase, GTP cyclohydrolase I, aromatic amino acid decarboxylase, and vesicular monoamine transporter 2 from a helper virus-free herpes simplex virus type 1 vector supports high-level, long-term biochemical and behavioral correction of a rat model of Parkinson's disease.

Guo-Rong Zhang, Alfred I Geller, Lingxin Kong, 2004, Human gene therapy.

Signalling pathways regulating nucleo-cytoplasmic shuttling of the mRNA-binding protein HuR.

J. Pfeilschifter, A. Doller, W. Eberhardt, 2008, Cellular signalling.

Regulation of eNOS in normal and diabetes-impaired skin repair: implications for tissue regeneration.

J. Pfeilschifter, B. Stallmeyer, Birgit Stallmeyer, 2002, Nitric oxide : biology and chemistry.

Cyclooxygenase‐independent actions of cyclooxygenase inhibitors

Gerd Geisslinger, J. Pfeilschifter, G. Geisslinger, 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

In-vivo interaction of nitric oxide and endothelin

Sebastian Bachmann, Christian Bauer, Torsten Slowinski, 2004, Journal of hypertension.

Prediction of Acute Renal Allograft Rejection by Urinary Monokine Induced by IFN-γ (MIG)

Helmut Geiger, Heinfried H. Radeke, H. Ackermann, 2005 .

Inhibition of Cytokine-induced Matrix Metalloproteinase 9 Expression by Peroxisome Proliferator-activated Receptor α Agonists Is Indirect and Due to a NO-mediated Reduction of mRNA Stability*

F. Hamada, J. Pfeilschifter, W. Eberhardt, 2002, The Journal of Biological Chemistry.

Controlling the cytokine storm by insulin: glycogen synthase kinase-3 as a target in systemic inflammation.

H. Mühl, J. Pfeilschifter, Josef Pfeilschifter, 2006, Critical care medicine.

Modulation of mRNA stability as a novel therapeutic approach.

J. Pfeilschifter, A. Doller, W. Eberhardt, 2007, Pharmacology & therapeutics.